Reach Us +1-947-333-4405


Assisted Reproductive Technology: Boon And Bane | 90343
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

World Congress on Pathology and Microbiology

Manila, Philippines
Google scholar citation report
Citations : 1147

Journal of Clinical & Experimental Pathology received 1147 citations as per google scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Assisted reproductive technology: Boon and bane

15th Global Experts Meeting on Pathology and Laboratory Medicine

Nor Ashikin Mohamed Noor Khan

Universiti Teknologi MARA, Malaysia

Keynote: J Clin Exp Pathol

DOI: 10.4172/2161-0681-C2-047

Infertility is a major concern worldwide. In 1972, birth of the first test tube baby, Louise Brown, set the tone for greater progress in Assisted Reproductive Technology (ART). Since then, ART procedures have become routine around the world. It has resulted in the birth of over five million babies worldwide. Although the extensive efforts to improve fertility have been much welcomed, research has shown that there are associated risks with either ART or infertility. Literature has brought forth evidence regarding birth defects, abnormalities in genomic imprinting and cardiovascular risks. This warrants a need for more thorough studies of the safety ART procedures.

Nor Ashikin Mohamed Noor Khan has completed her PhD in 2007 from University of Malaya in the area of Reproductive Biology and pursued Postdoctoral studies at Brigham and Women’s Hospital, Harvard Medical School. She Heads the Maternofetal and Embryo Research group at Universiti Teknologi MARA, Malaysia. She has published more than 50 papers in reputable journals. She is also currently serving as the Head of the Research Impact and Ethics Unit at the Institute of Research Management and Innovation of Universiti Teknologi MARA.

E-mail: [email protected]